Determinan Penerimaan Vaksin COVID-19 di Kabupaten Kerinci Tahun 2022: Studi Cross Sectional
Sari
ABSTRACT
Corona Virus Disease 2019 (COVID-19) is still a public health problem, including in Kerinci Regency. Various countermeasures have been carried out both globally and nationally. Efforts are made not only through prevention efforts through health protocols but also through vaccination efforts. Vaccines have proven to positively impact efforts to deal with the COVID-19 pandemic. The acceptance of the COVID-19 vaccine is one of the keys to fulfilling the COVID-19 vaccination achievements. Kerinci Regency is one of the districts in Jambi Province with low COVID-19 vaccination coverage, which is 66.20% as of August 28, 2022. This study aimed to determine the determinants of COVID-19 vaccine acceptance in Kerinci Regency. This study wss an analytic study using a cross sectional design conducted in Kerinci Regency in July 2022. The population of this study was all people aged ≥18 years who live in Kerinci Regency, with a sample of 300 people. Sampling used a 2-stage cluster method using Probability Proportional to Size (PPS). Villages used in this PPS were villages with COVID-19 vaccine coverage dose 2 <50%. Data were analyzed descriptively and analytically.The results showed that 54.7% of respondents who had received 2 or more doses of vaccine. Multivariate analysis showed that self-efficacy (aPR=1.764; 95%CI: 1.23-2.53) and education level (aPR=1.47; 95%CI: 1.05-2.07) were associated with receiving a complete dose of vaccine (dose 2 or more). The study found that self-efficacy was the most dominant risk factor for COVID-19 vaccine acceptance. Self-efficacy and education level are determinants of COVID-19 vaccine acceptance in Kerinci Regency. Health promotion efforts related to the COVID-19 vaccine need to be carried out by emphasizing self-efficacy and considering people at low education levels.
Keywords: COVID-19 Vaccine, Self-Efficacy, Education Level
ABSTRAK
Corona Virus Disease 2019 (COVID-19) masih menjadi masalah kesehatan masyarakat, termasuk di Kabupaten Kerinci. Berbagai upaya penanggulangan telah dilakukan baik secara global maupun nasional. Upaya yang dilakukan tidak hanya melalui upaya pencegahan melalui protokol kesehatan tetapi juga melalui upaya vaksinasi. Vaksin terbukti memberikan dampak positif terhadap upaya penanganan pandemi COVID-19. Penerimaan vaksin COVID-19 menjadi salah satu kunci pemenuhan capaian vaksinasi COVID-19. Kabupaten Kerinci merupakan salah satu kabupaten di Provinsi Jambi yang cakupan vaksinasi COVID-19-nya masih rendah, yaitu 66,20% per 28 Agustus 2022. Penelitian ini bertujuan untuk mengetahui determinan penerimaan vaksin COVID-19 di Kabupaten Kerinci. Penelitian ini merupakan penelitian analitik dengan menggunakan desain cross sectional yang dilakukan di Kabupaten Kerinci pada bulan Juli 2022. Populasi penelitian ini adalah seluruh masyarakat berusia ≥18 tahun yang berdomisili di Kabupaten Kerinci, dengan sampel sebanyak 300 orang. Pengambilan sampel menggunakan metode cluster 2 tahap dengan menggunakan Probability Proportional to Size (PPS). Desa yang digunakan dalam PPS ini adalah desa dengan cakupan vaksin COVID-19 dosis 2 <50%. Data dianalisis secara deskriptif dan analitik. Hasil penelitian menunjukkan bahwa responden yang telah menerima vaksin dosis 2 atau lebih sebesar 54,7%. Hasil analisis multivariate menunjukkan bahwa self-efficacy (aPR=1,764; 95%CI: 1,23-2,53) dan tingkat pendidikan (aPR=1,47; 95%CI: 1,05-2,07) berhubungan dengan penerimaan vaksin dosis lengkap (dosis 2 atau lebih). Penelitian menemukan bahwa self-efficacy merupakan faktor risiko yang paling dominan terhapad penerimaan vaksin COVID-19. Self-efficacy dan tingkat pendidikan merupakan determinan penerimaan vaksin COVID-19 di Kabupaten Kerinci. Upaya promosi kesehatan berkaitan dengan vaksin COVID-19 perlu dilakukan dengan menekankan pada self-efficacy dan mempertimbangkan masyarakat pada tingkat pendidikan rendah.
Kata Kunci: Vaksin COVID-19, Self-Efficacy, Tingkat Pendidikan
Kata Kunci
Teks Lengkap:
Download ArtikelReferensi
Abebe, H., Shitu, S., & Mose, A. (2021). Understanding Of Covid-19 Vaccine Knowledge, Attitude, Acceptance, And Determinates Of Covid-19 Vaccine Acceptance Among Adult Population In Ethiopia. Infection And Drug Resistance, 14, 2015.
Bandura, A. (2009). Self-Efficacy In Changing Societies,(Fourth Print). New York, Cambridge University Press.
Banik, R., Islam, M., Pranta, M. U. R., Rahman, Q. M., Rahman, M., Pardhan, S., Driscoll, R., Hossain, S., & Sikder, M. (2021). Understanding The Determinants Of Covid-19 Vaccination Intention And Willingness To Pay: Findings From A Population-Based Survey In Bangladesh. Bmc Infectious Diseases, 21(1), 1–15.
Berg, M. B., & Lin, L. (2021). Predictors Of Covid-19 Vaccine Intentions In The United States: The Role Of Psychosocial Health Constructs And Demographic Factors. Translational Behavioral Medicine, 11(9), 1782–1788.
Cdc. (2021). Basics Of Covid-19 | Cdc. Https://Www.Cdc.Gov/Coronavirus/2019-Ncov/Your-Health/About-Covid-19/Basics-Covid-19.Html
Cdc. (2023). Safety Of Covid-19 Vaccines | Cdc. Https://Www.Cdc.Gov/Coronavirus/2019-Ncov/Vaccines/Safety/Safety-Of-Vaccines.Html
Chen, H., Li, X., Gao, J., Liu, X., Mao, Y., Wang, R., Zheng, P., Xiao, Q., Jia, Y., & Fu, H. (2021). Health Belief Model Perspective On The Control Of Covid-19 Vaccine Hesitancy And The Promotion Of Vaccination In China: Web-Based Cross-Sectional Study. Journal Of Medical Internet Research, 23(9), E29329.
Coe, A. B., Elliott, M. H., Gatewood, S. B. S., Goode, J.-V. R., & Moczygemba, L. R. (2022). Perceptions And Predictors Of Intention To Receive The Covid-19 Vaccine. Research In Social And Administrative Pharmacy, 18(4), 2593–2599.
Detoc, M., Bruel, S., Frappe, P., Tardy, B., Botelho-Nevers, E., & Gagneux-Brunon, A. (2020). Intention To Participate In A Covid-19 Vaccine Clinical Trial And To Get Vaccinated Against Covid-19 In France During The Pandemic. Vaccine, 38(45), 7002–7006.
Diclemente, R. J., Salazar, L. F., & Crosby, R. A. (2019). Health Behavior Theory For Public Health: Principles, Foundations, And Applications (Second Edition). Jones & Bartlett Publishers.
Ezati Rad, R., Mohseni, S., Kamalzadeh Takhti, H., Hassani Azad, M., Shahabi, N., Aghamolaei, T., & Norozian, F. (2021). Application Of The Protection Motivation Theory For Predicting Covid-19 Preventive Behaviors In Hormozgan, Iran: A Cross-Sectional Study. Bmc Public Health, 21(1), 1–11.
Hayden, J. (2022). Introduction To Health Behavior Theory. Jones & Bartlett Learning.
Ishimaru, T., Okawara, M., Ando, H., Hino, A., Nagata, T., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y., & Project, Cor. (2021). Gender Differences In The Determinants Of Willingness To Get The Covid-19 Vaccine Among The Working-Age Population In Japan. Human Vaccines & Immunotherapeutics, 17(11), 3975–3981.
Kemenkes Ri. (2021). Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (Covid-19).
Kemenkes Ri. (2023a). Infeksi Emerging Kementerian Kesehatan Ri. Https://Infeksiemerging.Kemkes.Go.Id/Dashboard/Covid-19
Kemenkes Ri. (2023b). Vaksin Dashboard. Https://Vaksin.Kemkes.Go.Id/#/Provinces
Keputusan Menteri Kesehatan Republik Indonesia Nomor Hk.01.07/Menkes/4638/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (Covid-19), (2021).
Malik, A. A., Mcfadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants Of Covid-19 Vaccine Acceptance In The Us. Eclinicalmedicine, 26, 100495.
Nopriadi, N., & Fitri, A. (2022). A Promosi Kesehatan Tentang Upaya Pencegahan Dan Vaksinasi Covid-19 Di Puskesmas Siak Hulu I Kabupaten Kampar Tahun 2021: Musfardi Rustam, 1, 2 Nopriadi3, Aminatul Fitri 4. Jurnal Pengabdian Kesehatan Komunitas, 2(1), 74–80.
Patwary, M. M., Bardhan, M., Disha, A. S., Hasan, M., Haque, M., Sultana, R., Hossain, M., Browning, M. H. E. M., Alam, M., & Sallam, M. (2021). Determinants Of Covid-19 Vaccine Acceptance Among The Adult Population Of Bangladesh Using The Health Belief Model And The Theory Of Planned Behavior Model. Vaccines, 9(12), 1393.
Rohmah, S., Alamsyah, A., Sari, W., Susmaneli, H., & Desfita, S. (2022). Determinants Of Covid-19 Vaccination Status In Communities In The Work Area Of Puskesmas Rawat Inap Karya Wanita In 2022: Determinan Status Vaksinasi Covid-19 Pada Masyarakat Di Wilayah Kerja Puskesmas Rawat Inap Karya Wanita Tahun 2022. Jurnal Olahraga Dan Kesehatan (Orkes), 1(2), 471–482.
Satgas Covid-19 Provinsi Jambi. (2022). Cakupan Vaksinasi Covid-19 Provinsi Jambi Per 28 Agustus 2022.
Satgas Covid-19 Ri. (2022). Peta Sebaran | Covid19.Go.Id. Https://Covid19.Go.Id/Peta-Sebaran
Viinikainen, J., Bryson, A., Böckerman, P., Kari, J. T., Lehtimäki, T., Raitakari, O., Viikari, J., & Pehkonen, J. (2022). Does Better Education Mitigate Risky Health Behavior? A Mendelian Randomization Study. Economics & Human Biology, 46, 101134.
Who. (2020a). Coronavirus. Https://Www.Who.Int/Health-Topics/Coronavirus#Tab=Tab_3 (Diakses Tanggal 27 April 2020)
Who. (2020b). How Do Vaccines Work? Https://Www.Who.Int/News-Room/Feature-Stories/Detail/How-Do-Vaccines-Work?Gclid=Cjwkcajw_Yshbhaieiwamomseht42zij6_8xakbzzkwaiofohp6zjy0jqfqlqw5lvqpg7y2vzeixlhocchcqavd_Bwe
Who. (2022a). Covid-19 Vaccines Advice. Https://Www.Who.Int/Emergencies/Diseases/Novel-Coronavirus-2019/Covid-19-Vaccines/Advice
Who. (2022b). Safety Of Covid-19 Vaccines. Https://Www.Who.Int/News-Room/Feature-Stories/Detail/Safety-Of-Covid-19-Vaccines
Who. (2022c). Strategy To Achieve Global Covid-19 Vaccination By Mid-2022, 2021.
Who. (2023). Who Coronavirus (Covid-19) Dashboard | Who Coronavirus (Covid-19) Dashboard With Vaccination Data. Https://Covid19.Who.Int/
Wirawan, G. B. S., Harjana, N. P. A., Nugrahani, N. W., & Januraga, P. P. (2022). Health Beliefs And Socioeconomic Determinants Of Covid-19 Booster Vaccine Acceptance: An Indonesian Cross-Sectional Study. Vaccines, 10(5), 724.
DOI: https://doi.org/10.33024/mnj.v5i6.9831
Refbacks
- Saat ini tidak ada refbacks.
Penerbit: Universitas Malahayati
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License